REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: SEER-MEDICARE ANALYSIS

被引：0
|
作者：
Hamlin, P. [1 ]
Satram-Hoang, S. [2 ]
Reyes, C. [3 ]
Hoang, K. [2 ]
Guduru, S. [2 ]
Skettino, S. [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] QD Res Inc, Granite Bay, CA USA
[3] Genentech Inc, San Francisco, CA 94080 USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P843
引用
收藏
页码：353 / 353
页数：1
相关论文
共 50 条
  • [41] Real-world data for lenalidomide maintenance in responding patients of diffuse large B-cell lymphoma
    Wang, Xiaoyan
    Yu, Lu
    Jiang, Xinlu
    Ding, Kaiyang
    CANCER MEDICINE, 2023, 12 (09): : 10553 - 10562
  • [42] Real-World Treatment Patterns & Characteristics of Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Retrospective Analysis of US Claims (2017-2024)
    Burke, John M.
    Zhou, Ziqi
    Gutierrez, Cynthia
    Shao, Anran
    Boyd, Marley
    Noshad, Sina
    Hohlbauch, Andriana
    Liu, Nicholas
    Repetny, Karen
    Fanale, Michelle
    Mitchell, Betsy
    Phillips, Tycel
    BLOOD, 2024, 144 : 7810 - 7811
  • [43] Real-world clinical features and survival outcomes in diffuse large B-cell lymphoma patients with hepatitis B virus infection
    Yang, Wanxi
    Zhao, Xue
    Ma, Hongbing
    Xu, Caigang
    INFECTIOUS AGENTS AND CANCER, 2024, 19 (01):
  • [44] Efficacy and safety of orelabrutinib in diffuse large B-cell lymphoma: A real-world analysis.
    Xu, Peng-Peng
    Liu, Tingbo
    Li, Zengjun
    Li, Zheng
    Huang, Wei
    Zhou, Keshu
    Cai, Mingci
    Shen, Rong
    Zhao, Weili
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Treatment Patterns and Comparative Effectiveness in Elderly Diffuse Large B-Cell Lymphoma Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis
    Hamlin, Paul A.
    Satram-Hoang, Sacha
    Reyes, Carolina
    Hoang, Khang Q.
    Guduru, Sridhar R.
    Skettino, Sandra
    ONCOLOGIST, 2014, 19 (12): : 1249 - 1257
  • [46] Real-world assessment of treatment patterns and outcomes in patients with lenalidomide-refractory relapsed multiple myeloma from the SEER-Medicare database
    Dhakal, Binod
    Einsele, Hermann
    Potluri, Ravi
    Schecter, Jordan
    Deraedt, William
    Lendvai, Nikoletta
    Slaughter, Ana
    Lonardi, Carolina
    Nair, Sandhya
    He, Jianming
    Voelker, Jennifer
    Cost, Patricia
    Valluri, Satish
    Yalniz, Fevzi
    Pacaud, Lida
    Yong, Kwee
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S167 - S167
  • [47] Real-World Outcomes of Patients with Diffuse Large B-Cell Lymphoma Receiving Second Line Therapy in the United States
    Sawas, Ahmed
    Lau, Constance
    Thomson, Michael
    Maignan, Kathleen
    BLOOD, 2020, 136
  • [48] Characterizing Autoimmune Disease-Associated Diffuse Large B Cell Lymphoma in a SEER-Medicare Cohort
    Koff, Jean L.
    Rai, Ashish
    Flowers, Christopher
    BLOOD, 2016, 128 (22)
  • [49] Real-World Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Standard of Care: A Cota Database Analysis
    Ip, Andrew
    Mutebi, Alex
    Wang, Tongsheng
    Jun, Monika P.
    Kalsekar, Anupama
    Navarro, Fernando Rivas
    Wang, Anthony
    Kamalakar, Rajesh
    Sacchi, Mariana
    Elliott, Brian
    BLOOD, 2022, 140 : 6693 - 6694
  • [50] A Retrospective Analysis of US Commercial and Medicare Closed-Claims Databases to Evaluate Real-World Characteristics and Treatment Patterns of Patients with Diffuse Large B-Cell Lymphoma (2017-2023)
    Phillips, Tycel
    Zhou, Ziqi
    Gutierrez, Cynthia
    Shao, Anran
    Boyd, Marley
    Noshad, Sina
    Hohlbauch, Andriana
    Liu, Nicholas
    Repetny, Karen
    Fanale, Michelle
    Mitchell, Betsy
    Burke, John M.
    BLOOD, 2024, 144 : 7809 - 7810
12345